1. Home
  2. MTRX vs BCYC Comparison

MTRX vs BCYC Comparison

Compare MTRX & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matrix Service Company

MTRX

Matrix Service Company

HOLD

Current Price

$9.85

Market Cap

275.6M

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$3.85

Market Cap

291.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTRX
BCYC
Founded
1984
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.6M
291.8M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
MTRX
BCYC
Price
$9.85
$3.85
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $9.50
AVG Volume (30 Days)
474.9K
★ 477.7K
Earning Date
11-04-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 91.51
N/A
EPS
★ N/A
N/A
Revenue
★ $873,632,000.00
N/A
Revenue This Year
$6.70
N/A
Revenue Next Year
$5.71
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 13.56
N/A
52 Week Low
$9.38
$3.33
52 Week High
$15.97
$9.08

Technical Indicators

Market Signals
Indicator
MTRX
BCYC
Relative Strength Index (RSI) 46.02 54.64
Support Level $9.67 $3.44
Resistance Level $10.84 $3.99
Average True Range (ATR) 0.34 0.19
MACD -0.03 0.03
Stochastic Oscillator 42.46 86.27

Price Performance

Historical Comparison
MTRX
BCYC

About MTRX Matrix Service Company

Matrix Service Co provides engineering, fabrication, construction, and maintenance services supporting critical energy infrastructure and industrial markets. Its reportable segments are Storage and Terminal Solutions, Utility and Power Infrastructure, and Process and Industrial Facilities, with Storage and Terminal Solutions generating the maximum revenue. This segment provides integrated EPC, repair, maintenance, and fabrication services for bulk liquid, cryogenic, and refrigerated storage and terminal facilities supporting traditional and emerging energy markets, including LNG, NGLs, petroleum products, chemicals, hydrogen, and ammonia, and manufactures specialty tank products. The majority of revenue is generated from the United States.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: